계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
BrightPath Biotherapeutics
company
About
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥1.20B
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- May 8, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company develops products based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1.20B
BrightPath Biotherapeutics has raised a total of
¥1.20B
in funding over 2 rounds. Their latest funding was raised on
Aug 29, 2014 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 29, 2014 | Series Unknown | ¥1.20B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
BrightPath Biotherapeutics is funded by 1 investors.
Ibis Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Ibis Capital Partners
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
